Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.831
-0.056 (-6.36%)
At close: Dec 20, 2024, 4:00 PM
0.830
-0.001 (-0.12%)
After-hours: Dec 20, 2024, 6:45 PM EST
Oncolytics Biotech Market Cap
Oncolytics Biotech has a market cap or net worth of $63.82 million as of December 20, 2024. Its market cap has decreased by -34.68% in one year.
Market Cap
63.82M
Enterprise Value
50.92M
1-Year Change
-34.68%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since September 30, 2002, Oncolytics Biotech's market cap has increased from $30.90M to $63.82M, an increase of 106.52%. That is a compound annual growth rate of 3.31%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 20, 2024 | 64.00M | -32.06% |
Dec 29, 2023 | 94.20M | -0.95% |
Dec 30, 2022 | 95.10M | 24.48% |
Dec 31, 2021 | 76.40M | -24.21% |
Dec 31, 2020 | 100.80M | -15.44% |
Dec 31, 2019 | 119.20M | 341.48% |
Dec 31, 2018 | 27.00M | -60.93% |
Dec 29, 2017 | 69.10M | 178.63% |
Dec 30, 2016 | 24.80M | -1.59% |
Dec 31, 2015 | 25.20M | -43.88% |
Dec 31, 2014 | 44.90M | -62.24% |
Dec 31, 2013 | 118.90M | -57.43% |
Dec 31, 2012 | 279.30M | 5.40% |
Dec 30, 2011 | 265.00M | -35.74% |
Dec 31, 2010 | 412.40M | 260.49% |
Dec 31, 2009 | 114.40M | 129.72% |
Dec 31, 2008 | 49.80M | -20.70% |
Dec 31, 2007 | 62.80M | -17.04% |
Dec 29, 2006 | 75.70M | -49.09% |
Dec 30, 2005 | 148.70M | 19.06% |
Dec 31, 2004 | 124.90M | 47.81% |
Dec 31, 2003 | 84.50M | 194.43% |
Dec 31, 2002 | 28.70M | -7.12% |
View and export this data all the way back to 2002.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Vicarious Surgical | 71.08M |
ESSA Pharma | 71.02M |
Adicet Bio | 70.89M |
Clearside Biomedical | 70.53M |
FibroBiologics | 70.36M |
Werewolf Therapeutics | 69.96M |
Vivani Medical | 69.90M |
Regencell Bioscience Holdings | 68.06M |